MICHELLY DE CASTRO: Open Payments
NPI 1841687308 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,340 in 17 payments from 6 companies in 2025. Trend: 2023 $49 · 2024 $477 · 2025 $3,340
Consulting: $2,090Food & beverage: $754Travel & lodging: $397Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $2,656 |
| Janssen Scientific Affairs, LLC | 2 | $252 |
| PFIZER INC. | 2 | $205 |
| Kite Pharma, Inc. | 2 | $141 |
| Legend Biotech USA Inc. | 2 | $63 |
| Celgene Corporation | 1 | $23 |
Products named: CARVYKTI, ELREXFIO, TALVEY, DARZALEX, TECVAYLI, Yescarta, BREYANZI.
Industry payments across TX — which companies pay providers there.
